Amanote Research

Amanote Research

    RegisterSign In

Paclitaxel and Velcade: The Rationale for a Combo

Cancer Biology and Therapy - United States
doi 10.4161/cbt.4.6.1866
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncologyMolecular MedicinePharmacology
Date

June 1, 2005

Authors
Niklas FinnbergWafik S. El-Deiry
Publisher

Informa UK Limited


Related search

A New B-Raf Inhibitor Combo for Advanced Melanoma

Oncotarget
Oncology
2018English

Combo Drug Strategy Tested for PDAC

Cancer Discovery
Oncology
2019English

Combo Index

2020English

Targeted Combo Effective for Refractory Ewing Sarcoma

Cancer Discovery
Oncology
2012English

A Rationale for Reliabilism

Monist, The
Philosophy
1985English

Combo Therapy for Lung Cancer Extends Survival

Cancer Discovery
Oncology
2018English

Combo That, Please!

Science
MultidisciplinaryPhilosophy of ScienceHistory
2011English

The Treatment of Traumatic Brain Injury With Velcade

Journal of Neurotrauma
Neurology
2010English

Atezolizumab Combo Approved for PD-L1–positive TNBC

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy